Nebula Genomics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14.6M
Nebula Genomics General Information
Description
Developer of a DNA sequencing technology designed to make direct-to-consumer DNA testing secure. The company's technology offers the sequencing of all genes (coding regions), regulatory genomic regions, the Y chromosome, and mitochondrial DNA, thereby enabling clients to examine any gene in the genome, search for genetic variants, and browse through all the sequence information.
Contact Information
Website
www.nebula.org(Operating Subsidiary)
Corporate Office
- 711 Stewart Avenue
- Suite 200
- Garden City, NY 11530
- United States
Corporate Office
- 711 Stewart Avenue
- Suite 200
- Garden City, NY 11530
- United States
Nebula Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 11-Aug-2021 | $14.6M | Completed | Generating Revenue | ||
| 1. Seed Round | 29-Aug-2018 | Completed | Generating Revenue |
Nebula Genomics Comparisons
Industry
Financing
Details
Nebula Genomics Competitors (30)
One of Nebula Genomics’s 30 competitors is Genomenon, a Venture Capital-Backed company based in Ann Arbor, MI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomenon | Venture Capital-Backed | Ann Arbor, MI | ||||
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| Oxford Nanopore Technologies | Formerly VC-backed | Oxford, United Kingdom | ||||
| DNAnexus | Venture Capital-Backed | Mountain View, CA | ||||
| Partek | Corporate Backed or Acquired | Chesterfield, MO |
Nebula Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nebula Genomics Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| F-Prime Capital | Venture Capital | Minority | ||
| Fenbushi Capital | Venture Capital | Minority | ||
| GreatPoint Ventures | Venture Capital | Minority | ||
| Heartbeat Labs | Venture Capital | Minority |
Nebula Genomics FAQs
-
When was Nebula Genomics founded?
Nebula Genomics was founded in 2016.
-
Where is Nebula Genomics headquartered?
Nebula Genomics is headquartered in Garden City, NY.
-
What is the size of Nebula Genomics?
Nebula Genomics has 9 total employees.
-
What industry is Nebula Genomics in?
Nebula Genomics’s primary industry is Biotechnology.
-
Is Nebula Genomics a private or public company?
Nebula Genomics is a Private company.
-
What is the current valuation of Nebula Genomics?
The current valuation of Nebula Genomics is .
-
What is Nebula Genomics’s current revenue?
The current revenue for Nebula Genomics is .
-
How much funding has Nebula Genomics raised over time?
Nebula Genomics has raised $4.3M.
-
Who are Nebula Genomics’s investors?
ARCH Venture Partners, F-Prime Capital, Fenbushi Capital, GreatPoint Ventures, and Heartbeat Labs are 5 of 12 investors who have invested in Nebula Genomics.
-
Who are Nebula Genomics’s competitors?
Genomenon, Gene By Gene, Oxford Nanopore Technologies, DNAnexus, and Partek are some of the 30 competitors of Nebula Genomics.
-
When was Nebula Genomics acquired?
Nebula Genomics was acquired on 11-Aug-2021.
-
Who acquired Nebula Genomics?
Nebula Genomics was acquired by Prophase Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
